arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

InnovAge Holding Corp.

INNV
$9.01 ▼ -1.65 (-15.49%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
8 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
35
Health
Weak
Bearish
auto_awesome

Analytical Summary

InnovAge Holding Corp. faces fundamental challenges with weakness in Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.2B
Dividend Yield —
Revenue Growth 15.9% ↗
Op. Margin 0.3% ↗
ROIC 0.7% ↗
FCF / Share $0.37 ↗
Trailing P/E —
Price / Book 5.2x
FCF Yield 4.1%
Debt / Equity 0.21
info Valuation on last close. End-of-day price, Sep 23, 2026.

8-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$989.71M
↑ +15.9% —
Net Income Profit after all expenses
$-2.54M
↑ +91.6% —
Operating Margin Operating profit as % of sales
0.3%
↑ +107.6% 25th
FCF / Share Free cash flow per share
$0.37
↑ +89.0% —
Long-Term Debt Long-term obligations
$48.81M
↓ -18.6% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
30
Returns ↑
37
Financial Health ↓
58
Cash Quality
1

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 8 years · 28 quarters